Indication

CRP

1 clinical trial

1 product

Clinical trial

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Quarterly and Monthly TOUR006 in Participants With Chronic Kidney Disease and Elevated High-Sensitivity C-Reactive Protein

Status: Recruiting, Estimated PCD: 2025-05-01

Product